212 related articles for article (PubMed ID: 21597380)
1. Predictors and risk model development for menopausal age in fragile X premutation carriers.
Spath MA; Feuth TB; Smits AP; Yntema HG; Braat DD; Thomas CM; van Kessel AG; Sherman SL; Allen EG
Genet Med; 2011 Jul; 13(7):643-50. PubMed ID: 21597380
[TBL] [Abstract][Full Text] [Related]
2. Fragile X-associated primary ovarian insufficiency: evidence for additional genetic contributions to severity.
Hunter JE; Epstein MP; Tinker SW; Charen KH; Sherman SL
Genet Epidemiol; 2008 Sep; 32(6):553-9. PubMed ID: 18357616
[TBL] [Abstract][Full Text] [Related]
3. Curvilinear association of CGG repeats and age at menopause in women with FMR1 premutation expansions.
Mailick MR; Hong J; Greenberg J; Smith L; Sherman S
Am J Med Genet B Neuropsychiatr Genet; 2014 Dec; 165B(8):705-11. PubMed ID: 25346430
[TBL] [Abstract][Full Text] [Related]
4. [FMR1 PREMUTATION CARRIERS - ARE THEY REALLY ASYMPTOMATIC?].
Elizur S; Berkenstadt M; Ries-Levavi L; Gruber N; Pinhas-Hamiel O; Hassin-Baer S; Raas-Rothschild A; Raanani H; Cukierman-Yaffe T; Orvieto R; Cohen Y; Gabis L
Harefuah; 2018 Apr; 157(4):241-244. PubMed ID: 29688643
[TBL] [Abstract][Full Text] [Related]
5. Nonlinear association between CGG repeat number and age of menopause in FMR1 premutation carriers.
Ennis S; Ward D; Murray A
Eur J Hum Genet; 2006 Feb; 14(2):253-5. PubMed ID: 16251893
[TBL] [Abstract][Full Text] [Related]
6. Fragile X premutation in women: recognizing the health challenges beyond primary ovarian insufficiency.
Hoyos LR; Thakur M
J Assist Reprod Genet; 2017 Mar; 34(3):315-323. PubMed ID: 27995424
[TBL] [Abstract][Full Text] [Related]
7. Fragile x-associated premature ovarian failure in a large Turkish cohort: Findings of Hacettepe Fragile X Registry.
Utine GE; Şimşek-Kiper PÖ; Akgün-Doğan Ö; Ürel-Demir G; Alanay Y; Aktaş D; Boduroğlu K; Tunçbilek E; Alikaşifoğlu M
Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():76-80. PubMed ID: 29275276
[TBL] [Abstract][Full Text] [Related]
8. The significance of fragile X mental retardation gene 1 CGG repeat sizes in the normal and intermediate range in women with primary ovarian insufficiency.
Voorhuis M; Onland-Moret NC; Janse F; Ploos van Amstel HK; Goverde AJ; Lambalk CB; Laven JS; van der Schouw YT; Broekmans FJ; Fauser BC;
Hum Reprod; 2014 Jul; 29(7):1585-93. PubMed ID: 24812319
[TBL] [Abstract][Full Text] [Related]
9. Presence of inclusions positive for polyglycine containing protein, FMRpolyG, indicates that repeat-associated non-AUG translation plays a role in fragile X-associated primary ovarian insufficiency.
Buijsen RA; Visser JA; Kramer P; Severijnen EA; Gearing M; Charlet-Berguerand N; Sherman SL; Berman RF; Willemsen R; Hukema RK
Hum Reprod; 2016 Jan; 31(1):158-68. PubMed ID: 26537920
[TBL] [Abstract][Full Text] [Related]
10. Understanding decreased fertility in women carriers of the FMR1 premutation: a possible mechanism for Fragile X-Associated Primary Ovarian Insufficiency (FXPOI).
Peprah E
Reprod Health; 2014 Aug; 11():67. PubMed ID: 25134882
[TBL] [Abstract][Full Text] [Related]
11. FMR1 CGG repeat length predicts motor dysfunction in premutation carriers.
Leehey MA; Berry-Kravis E; Goetz CG; Zhang L; Hall DA; Li L; Rice CD; Lara R; Cogswell J; Reynolds A; Gane L; Jacquemont S; Tassone F; Grigsby J; Hagerman RJ; Hagerman PJ
Neurology; 2008 Apr; 70(16 Pt 2):1397-402. PubMed ID: 18057320
[TBL] [Abstract][Full Text] [Related]
12. The ovarian response in fragile X patients and premutation carriers undergoing IVF-PGD: reappraisal.
Avraham S; Almog B; Reches A; Zakar L; Malcov M; Sokolov A; Alpern S; Azem F
Hum Reprod; 2017 Jul; 32(7):1508-1511. PubMed ID: 28472405
[TBL] [Abstract][Full Text] [Related]
13. Fragile X premutation RNA is sufficient to cause primary ovarian insufficiency in mice.
Lu C; Lin L; Tan H; Wu H; Sherman SL; Gao F; Jin P; Chen D
Hum Mol Genet; 2012 Dec; 21(23):5039-47. PubMed ID: 22914733
[TBL] [Abstract][Full Text] [Related]
14. Does theFMR1 gene affect IVF success?
Pastore LM; Christianson MS; McGuinness B; Vaught KC; Maher JY; Kearns WG
Reprod Biomed Online; 2019 Apr; 38(4):560-569. PubMed ID: 30711457
[TBL] [Abstract][Full Text] [Related]
15. Unstable mutations in the FMR1 gene and the phenotypes.
Loesch D; Hagerman R
Adv Exp Med Biol; 2012; 769():78-114. PubMed ID: 23560306
[TBL] [Abstract][Full Text] [Related]
16. X chromosome inactivation does not define the development of premature ovarian failure in fragile X premutation carriers.
Spath MA; Nillesen WN; Smits AP; Feuth TB; Braat DD; van Kessel AG; Yntema HG
Am J Med Genet A; 2010 Feb; 152A(2):387-93. PubMed ID: 20101683
[TBL] [Abstract][Full Text] [Related]
17. Identifying susceptibility genes for primary ovarian insufficiency on the high-risk genetic background of a fragile X premutation.
Trevino CE; Rounds JC; Charen K; Shubeck L; Hipp HS; Spencer JB; Johnston HR; Cutler DJ; Zwick ME; Epstein MP; Murray A; Macpherson JN; Mila M; Rodriguez-Revenga L; Berry-Kravis E; Hall DA; Leehey MA; Liu Y; Welt C; Warren ST; Sherman SL; Jin P; Allen EG
Fertil Steril; 2021 Sep; 116(3):843-854. PubMed ID: 34016428
[TBL] [Abstract][Full Text] [Related]
18. FMR1 premutation carrier frequency in patients undergoing routine population-based carrier screening: insights into the prevalence of fragile X syndrome, fragile X-associated tremor/ataxia syndrome, and fragile X-associated primary ovarian insufficiency in the United States.
Hantash FM; Goos DM; Crossley B; Anderson B; Zhang K; Sun W; Strom CM
Genet Med; 2011 Jan; 13(1):39-45. PubMed ID: 21116185
[TBL] [Abstract][Full Text] [Related]
19. Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutations.
Hundscheid RD; Sistermans EA; Thomas CM; Braat DD; Straatman H; Kiemeney LA; Oostra BA; Smits AP
Am J Hum Genet; 2000 Feb; 66(2):413-8. PubMed ID: 10677300
[TBL] [Abstract][Full Text] [Related]
20. Age- and CGG repeat-related slowing of manual movement in fragile X carriers: A prodrome of fragile X-associated tremor ataxia syndrome?
Shickman R; Famula J; Tassone F; Leehey M; Ferrer E; Rivera SM; Hessl D
Mov Disord; 2018 Apr; 33(4):628-636. PubMed ID: 29389022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
